This company listing is no longer active
Taiwan Leader Biotech Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
18.2%
Tasa de crecimiento de los beneficios
21.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Personal Products | 13.9% |
| Tasa de crecimiento de los ingresos | -9.4% |
| Rentabilidad financiera | -12.6% |
| Margen neto | -74.0% |
| Última actualización de beneficios | 30 Jun 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Taiwan Leader Biotech. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 22 | 40 | -30 | 29 | 12 |
| 31 Mar 22 | 41 | -29 | 30 | 12 |
| 31 Dec 21 | 42 | -29 | 30 | 12 |
| 30 Sep 21 | 39 | -31 | 30 | 13 |
| 30 Jun 21 | 37 | -33 | 31 | 13 |
| 31 Mar 21 | 32 | -43 | 33 | 15 |
| 31 Dec 20 | 28 | -52 | 36 | 18 |
| 30 Sep 20 | 29 | -56 | 39 | 20 |
| 30 Jun 20 | 30 | -60 | 42 | 23 |
| 31 Mar 20 | 31 | -56 | 40 | 23 |
| 31 Dec 19 | 31 | -51 | 39 | 23 |
| 30 Sep 19 | 29 | -71 | 56 | 26 |
| 30 Jun 19 | 27 | -90 | 73 | 28 |
| 31 Mar 19 | 51 | -84 | 76 | 34 |
| 31 Dec 18 | 74 | -78 | 78 | 39 |
| 30 Sep 18 | 77 | -64 | 65 | 38 |
| 30 Jun 18 | 79 | -51 | 52 | 36 |
| 31 Mar 18 | 55 | -64 | 55 | 33 |
| 31 Dec 17 | 30 | -77 | 59 | 31 |
| 30 Sep 17 | 38 | -77 | 58 | 38 |
| 30 Jun 17 | 45 | -77 | 58 | 46 |
| 31 Mar 17 | 44 | -78 | 55 | 48 |
| 31 Dec 16 | 42 | -78 | 52 | 51 |
| 30 Sep 16 | 31 | -88 | 50 | 55 |
| 30 Jun 16 | 20 | -98 | 48 | 60 |
| 31 Mar 16 | 19 | -92 | 48 | 55 |
Ingresos de calidad: 8490 is currently unprofitable.
Margen de beneficios creciente: 8490 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 8490 is unprofitable, but has reduced losses over the past 5 years at a rate of 18.2% per year.
Acelerando crecimiento: Unable to compare 8490's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: 8490 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-4.7%).
Rentabilidad financiera
Alta ROE: 8490 has a negative Return on Equity (-12.62%), as it is currently unprofitable.